BGI Genomics Co., Ltd., a leading player in the genomics industry, is headquartered in Shenzhen, China. Founded in 1999, the company has established itself as a pioneer in genomic research and biotechnology, with significant operations across Asia, Europe, and North America. BGI Genomics is renowned for its advanced sequencing services, bioinformatics solutions, and innovative genomic technologies, which cater to a diverse range of sectors, including healthcare, agriculture, and environmental science. With a commitment to making genomic information accessible, BGI Genomics has achieved notable milestones, such as the rapid sequencing of the human genome and contributions to large-scale population genomics projects. The company’s unique offerings, including its proprietary sequencing platforms and comprehensive data analysis services, position it as a key player in the global genomics market, driving advancements in personalised medicine and research.
How does BGI Genomics Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
BGI Genomics Co., Ltd.'s score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
BGI Genomics Co., Ltd., headquartered in China (CN), currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary, BGI Genomics may inherit climate-related data and initiatives from its parent organisation, but specific details regarding such cascaded information are not available. The company has not outlined any commitments to the Science Based Targets initiative (SBTi) or other industry-standard climate initiatives, which limits the visibility of its climate strategy. In the context of the genomics industry, companies are increasingly expected to adopt robust climate commitments and transparency in emissions reporting. However, without specific data or targets, BGI Genomics' position on carbon emissions and climate action remains unclear.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
BGI Genomics Co., Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.